The Latest Breaking News from Breast Cancer

A study of half a million people has found that diary eaters might have an increased risk of three types of cancers

Between December 2016 and January 2017 Tracey Pinfold, 50, and Cathy Corr, 47, originally of Northern Ireland, found out they both had breast cancer

The FDA has approved AstraZeneca plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKYF) Enhertu (trastuzumab deruxtecan) for adult patients with unresectable or metastatic HER2-positive breast cancer. The approval covers patients who have received a prior anti-HER2-based regimen either in the metastatic setting or in the neoadjuvant or adjuvant setting and have developed disease recurrence during or within…

Here's a roundup of top developments in the biotech space over the last 24 hours:

Lynsey Ritchie is now inspiring others with an emotional audio recording ahead of Cancer Research UK's Race for Life events.

Dieticians have claimed if a person loses just 7lb can do wonders for your physical health immediately and long-term.

When you hear the word “nanomedicine,” it might call to mind scenarios like those in the 1966 movie “Fantastic Voyage.” The film portrays a medical team shrunken down to ride a microscopic robotic ship through a man’s body to clear a blood clot in his brain.

Dieticians believe shedding just 7lb can do wonders for your physical health in many ways

Novartis AG (NYSE:NVS) has announced updated median overall survival (OS) results for Kisqali (ribociclib) combined with fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.  The analysis of patients treated in first-line with Kisqali plus fulvestrant demonstrated a significant OS benefit of nearly…